The disclosure relates to a method for producing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for producing medicaments and for producing medicaments for the treatment and/or prophylaxis of cardiovascular disorders. In particular, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for producing compounds which serves for producing medicaments, for producing medicaments for the treatment and/or prophylaxis of cardiovascular disorders.
